United States. Congress. House. Committee on Government Reform and Oversight & ProQuest (Firm). (1998). Clinical trial subjects: Adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Government Reform and Oversight and ProQuest (Firm). Clinical Trial Subjects: Adequate FDA Protections? : Hearing Before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, Second Session, April 22, 1998. Washington: U.S. G.P.O., 1998.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Government Reform and Oversight and ProQuest (Firm). Clinical Trial Subjects: Adequate FDA Protections? : Hearing Before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, Second Session, April 22, 1998. U.S. G.P.O., 1998.